Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Metronom Health

2009 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series E LATEST DEAL TYPE
$7M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a next generation monitoring system designed to provide treatment of type 1 diabetes. The company's next generation monitoring system is a continuous glucose-monitoring system for type 1 diabetes management.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 26051 Merit Circle
  • Suite 102
  • Laguna Hills, CA 92653
  • United States

+1 (949) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Metronom Health’s full profile, request a free trial.

Metronom Health Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series E) 03-Jan-2019 $7M 000.00 0000 Completed Generating Revenue
4. Later Stage VC (Series D) 15-Mar-2017 000.00 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 04-Jan-2017 00.000 000.00 0000 Completed Startup
2. Early Stage VC (Series B) 27-Jul-2011 $1.5M $2.85M 00.00 Completed Startup
1. Early Stage VC (Series A) 19-Nov-2010 $1.35M $1.35M 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Metronom Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series D 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 290,135 $0.001000 8% $5.17 $5.17 1x $5.17 5.93%
Series A 300,001 $0.001000 8% $4.5 $4.5 1x $4.5 6.13%
To view this company’s complete Cap Table, request access »

Metronom Health Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Fjord Ventures Venture Capital Minority 000 0000 000000 0

Metronom Health Executive Team (6)

Name Title Board
Seat
Contact
Info
Michel Lussier Chief Executive Officer
Hugh Neuharth Chief Financial Officer
Troy Bremer Ph.D Co-Founder and Chief Scientific Officer
Elliot Botvinick Ph.D Co-Founder
Olav Bergheim Co-Founder
You’re viewing 5 of 6 executives. Get the full list »